Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W CLARKE

Showing results (771-780 of 856) with videos related to

Pageof 86
Sort By:
Journal of AOAC International|August 3, 2017
General Steps to Standardize the Laboratory Measurement of Serum Total 25-Hydroxyvitamin DChristopher T Sempos, Joseph M Betz, Johanna E Camara, et al.
The Lancet. Oncology|March 8, 2013
Cardiovascular outcomes in patients with locally advanced and metastatic prostate cancer treated with luteinising-hormone-releasing-hormone agonists or transdermal oestrogen: the randomised, phase 2 MRC PATCH trial (PR09)Ruth E Langley, Fay H Cafferty, Abdulla A Alhasso, et al.
The Lancet. Oncology|January 1, 2016
Addition of docetaxel or bisphosphonates to standard of care in men with localised or metastatic, hormone-sensitive prostate cancer: a systematic review and meta-analyses of aggregate dataClaire L Vale, Sarah Burdett, Larysa H M Rydzewska, et al.
Endocrine Connections|October 25, 2022
Maintaining bone health by estrogen therapy in patients with advanced prostate cancer: a narrative reviewHerjan J T Coelingh Bennink, Jan Krijgh, Jan F M Egberts, et al.
Science (New York, N.Y.)|August 22, 2024
Manufacture and testing of biomass-derivable thermosets for wind blade recyclingRyan W Clarke, Erik G Rognerud, Allen Puente-Urbina, et al.
European Journal of Cancer (Oxford, England : 1990)|August 12, 2017
Adding abiraterone to androgen deprivation therapy in men with metastatic hormone-sensitive prostate cancer: A systematic review and meta-analysisLarysa H M Rydzewska, Sarah Burdett, Claire L Vale, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 11, 2017
Metastasis-Free Survival Is a Strong Surrogate of Overall Survival in Localized Prostate CancerWanling Xie, Meredith M Regan, Marc Buyse, et al.
Contemporary Clinical Trials|March 18, 2023
Healthcare systems data in the context of clinical trials - A comparison of cardiovascular data from a clinical trial dataset with routinely collected dataArchie Macnair, Matthew Nankivell, Macey L Murray, et al.
JAMA Oncology|February 18, 2021
Association of Bone Metastatic Burden With Survival Benefit From Prostate Radiotherapy in Patients With Newly Diagnosed Metastatic Prostate Cancer: A Secondary Analysis of a Randomized Clinical TrialAdnan Ali, Alex Hoyle, Áine M Haran, et al.
Trials|September 18, 2012
Flexible trial design in practice - stopping arms for lack-of-benefit and adding research arms mid-trial in STAMPEDE: a multi-arm multi-stage randomized controlled trialMatthew R Sydes, Mahesh K B Parmar, Malcolm D Mason, et al.
Pageof 86

Showing results (771-780 of 856) with videos related to

Sort By:
Pageof 86
Journal of AOAC International|August 3, 2017
General Steps to Standardize the Laboratory Measurement of Serum Total 25-Hydroxyvitamin DChristopher T Sempos, Joseph M Betz, Johanna E Camara, et al.
The Lancet. Oncology|March 8, 2013
Cardiovascular outcomes in patients with locally advanced and metastatic prostate cancer treated with luteinising-hormone-releasing-hormone agonists or transdermal oestrogen: the randomised, phase 2 MRC PATCH trial (PR09)Ruth E Langley, Fay H Cafferty, Abdulla A Alhasso, et al.
The Lancet. Oncology|January 1, 2016
Addition of docetaxel or bisphosphonates to standard of care in men with localised or metastatic, hormone-sensitive prostate cancer: a systematic review and meta-analyses of aggregate dataClaire L Vale, Sarah Burdett, Larysa H M Rydzewska, et al.
Endocrine Connections|October 25, 2022
Maintaining bone health by estrogen therapy in patients with advanced prostate cancer: a narrative reviewHerjan J T Coelingh Bennink, Jan Krijgh, Jan F M Egberts, et al.
Science (New York, N.Y.)|August 22, 2024
Manufacture and testing of biomass-derivable thermosets for wind blade recyclingRyan W Clarke, Erik G Rognerud, Allen Puente-Urbina, et al.
European Journal of Cancer (Oxford, England : 1990)|August 12, 2017
Adding abiraterone to androgen deprivation therapy in men with metastatic hormone-sensitive prostate cancer: A systematic review and meta-analysisLarysa H M Rydzewska, Sarah Burdett, Claire L Vale, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 11, 2017
Metastasis-Free Survival Is a Strong Surrogate of Overall Survival in Localized Prostate CancerWanling Xie, Meredith M Regan, Marc Buyse, et al.
Contemporary Clinical Trials|March 18, 2023
Healthcare systems data in the context of clinical trials - A comparison of cardiovascular data from a clinical trial dataset with routinely collected dataArchie Macnair, Matthew Nankivell, Macey L Murray, et al.
JAMA Oncology|February 18, 2021
Association of Bone Metastatic Burden With Survival Benefit From Prostate Radiotherapy in Patients With Newly Diagnosed Metastatic Prostate Cancer: A Secondary Analysis of a Randomized Clinical TrialAdnan Ali, Alex Hoyle, Áine M Haran, et al.
Trials|September 18, 2012
Flexible trial design in practice - stopping arms for lack-of-benefit and adding research arms mid-trial in STAMPEDE: a multi-arm multi-stage randomized controlled trialMatthew R Sydes, Mahesh K B Parmar, Malcolm D Mason, et al.
Pageof 86